Eisai Inc. was established in 1995 and began marketing its first product in the United States in 1997. Since then we have rapidly grown to become a fully integrated pharmaceutical business. Eisai’s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.
Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina. The company’s areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs.
Eisai recognizes that we are the Company’s greatest asset. To this, Eisai is committed to providing us an enabling and empowering work environment that allows us to grow and thrive. In our diverse organization, we adhere to a strict commitment to our values of Integrity, Respect, Professionalism, Quality and Teamwork. We therefore invite you to explore this job opportunity or any others that may match your qualifications and interests.
The Clinical Pharmacology and Translational Medicine Group in the Eisai Oncology Product Creation Unit (PCU) is seeking an (Associate) Director to drive all clinical pharmacologic aspects of multiple projects within the PCU. The goal of the ONC Clinical Pharmacology and Translational Medicine group is to provide a high quality, science-based understanding of the pharmacology of drugs in development to permit effective, science-based, early and late phase decisions to be made for each compound in development by the Eisai PCU. To this end, the candidate should be competent in non-parametric and population pharmacokinetic (PK) analysis of data and the integration of pharmacodynamic (PD) data sets (broadly defined and including multi-parameter profiling [-omics] approaches) with the PK data and interpretation thereof. The candidate will be hands-on. They will be expected to apply innovative and analytical thinking to the entirety of the clinical pharmacology, PK, and PK/PD analyses (from collaborating with pre-clinical scientists and bioanalytical scientists, to conceptualization and execution of protocols, integration of the pharmacokinetic and pharmacodynamic data, to interacting with Regulatory Affairs specialists). The position is office/computer based (not laboratory-based) and the candidate will be expected to interact regularly, credibly and effectively with pre-clinical scientists, bioanalytical scientists, modelers, various contract research labs, outside scientists and clinicians. The candidate will work both independently and in a cooperative team-based environment across the broad portfolio of small and large molecule drugs in development within the Eisai Oncology PCU.
See Job Description
Here at Eisai, we are rewarded with highly competitive salaries, incentive awards, a comprehensive benefits package (Medical, Dental, Prescription and Vision Plans) 401k, Flexible Spending Accounts, Life and Disability Insurance, and other great programs.
Eisai is committed to a policy of equal employment opportunity for all employees and applicants. The Company also strives for a work environment free from discrimination and harassment. It is Eisai’s policy to comply with all applicable federal, state and local laws and regulations regarding nondiscrimination in employment and not to discriminate against any employee or applicant for employment on the basis of any protected status, including, but not limited to, race, color, national origin, religion, sex, age, disability, pregnancy, ancestry, creed, alienage or citizenship status, sexual orientation, gender identity and expression, marital status, military/veteran status, genetic information, or any other protected characteristic as established by law.